Loading...
Compumedics Limited
CMP.AX•ASX
Healthcare
Medical - Devices
A$0.35
A$0.03(11.11%)
Compumedics Limited (CMP.AX) Financial Performance & Income Statement Overview
Review Compumedics Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
17.24%
↑ 17.24%
Operating Income Growth
92.39%
↑ 92.39%
Net Income Growth
94.48%
↑ 94.48%
Operating Cash Flow Growth
3983.76%
↑ 3983.76%
Operating Margin
-3.13%
↓ 3.13%
Gross Margin
51.51%
↑ 51.51%
Net Profit Margin
-3.75%
↓ 3.75%
ROE
-8.86%
↓ 8.86%
ROIC
-6.64%
↓ 6.64%
Compumedics Limited (CMP.AX) Income Statement & Financial Overview
Review Compumedics Limited's (CMP.AX) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $23.30M | $26.41M | $23.20M | $19.20M |
| Cost of Revenue | $12.02M | $11.89M | $11.16M | $9.66M |
| Gross Profit | $11.29M | $14.52M | $12.04M | $9.55M |
| Gross Profit Ratio | $0.48 | $0.55 | $0.52 | $0.50 |
| R&D Expenses | $1.40M | $4.34M | $1.58M | $7.03M |
| SG&A Expenses | $10.83M | $10.28M | $8.54M | $11.12M |
| Operating Expenses | $12.23M | $14.62M | $8.54M | $18.15M |
| Total Costs & Expenses | $24.25M | $26.51M | $19.70M | $27.81M |
| Interest Income | $0.00 | $0.00 | $345000.00 | $307000.00 |
| Interest Expense | $312000.00 | $427000.00 | $345000.00 | $307000.00 |
| Depreciation & Amortization | $635000.00 | $857000.00 | $547000.00 | $3.55M |
| EBITDA | $544000.00 | $229000.00 | $2.56M | -$4.79M |
| EBITDA Ratio | $0.02 | $0.03 | $0.17 | -$0.26 |
| Operating Income | -$942000.00 | -$99000.00 | $3.50M | -$8.60M |
| Operating Income Ratio | -$0.04 | -$0.004 | $0.15 | -$0.45 |
| Other Income/Expenses (Net) | $543000.00 | $994000.00 | -$567000.00 | -$45000.00 |
| Income Before Tax | -$399000.00 | $879000.00 | $1.93M | -$8.65M |
| Income Before Tax Ratio | -$0.02 | $0.03 | $0.08 | -$0.45 |
| Income Tax Expense | $80000.00 | $738000.00 | $837000.00 | -$1.43M |
| Net Income | -$640000.00 | $141000.00 | $1.09M | -$7.21M |
| Net Income Ratio | -$0.03 | $0.005 | $0.05 | -$0.38 |
| EPS | -$0.003 | $0.001 | $0.006 | -$0.04 |
| Diluted EPS | -$0.003 | $0.001 | $0.006 | -$0.04 |
| Weighted Avg Shares Outstanding | $177.16M | $177.16M | $177.16M | $177.16M |
| Weighted Avg Shares Outstanding (Diluted) | $177.16M | $177.16M | $177.16M | $177.16M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan